Andrew Edet Ekpenyong

Title: Innovations in Cancer Treatment by Andrew Edet Ekpenyong

Introduction

Andrew Edet Ekpenyong is an innovative inventor based in Omaha, NE (US). He has made significant contributions to the field of cancer treatment through his groundbreaking patent. His work focuses on enhancing radiation therapy for cancerous tumors using advanced technology.

Latest Patents

Andrew Edet Ekpenyong holds a patent titled "Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis." This patent describes systems and methods for radiation therapy that utilize biocompatible quantum dots. The approach aims to provide radiation dose enhancement while also resisting metastasis. The method involves preparing a radiosensitizer fluid containing a plurality of biocompatible quantum dots, introducing this fluid to cancer cells, and irradiating the cells to promote the generation of reactive oxygen species. This innovative technique inhibits radiation-induced enhancement of cell migration.

Career Highlights

Andrew is associated with Creighton University, where he continues to advance his research in cancer therapy. His work is pivotal in developing new methods that could potentially improve patient outcomes in cancer treatment.

Collaborations

Some of his notable coworkers include Caleb Thiegs and Anne Hubbard. Their collaboration contributes to the innovative research environment at Creighton University.

Conclusion

Andrew Edet Ekpenyong's contributions to cancer treatment through his patent demonstrate the potential of biocompatible quantum dots in enhancing radiation therapy. His work is a significant step forward in the fight against cancer.